DuPont Decomposition

Why does THYROCARE earn its ROE?

Breaking down Return on Equity into profitability, efficiency, and leverage.

ROE = Net Margin × Asset Turnover × Equity Multiplier

16.7% = 13.3% × 0.99 × 1.27

Latest: FY2025

Profitability

Net Margin

13.3%

9.2% →13.3%

How much profit per ₹ of revenue

Efficiency

Asset Turnover

0.99x

0.21x →0.99x

Revenue per ₹ of assets

Leverage

Equity Multiplier

1.27x

1.18x →1.27x

Assets funded by equity vs debt

Trend Analysis

ROE improved by 14.4 pp over 3 years. Driven by net margin improving (9.2% → 13.3%), asset turnover improving (0.21x → 0.99x).

Historical Decomposition

Last 3 years

YearRevenuePATNet MarginAsset TOLeverageROE
FY20230Cr0Cr9.2%0.211.182.3%
FY20240Cr0Cr13.6%0.231.213.7%
FY20250Cr0Cr13.3%0.991.2716.7%

How to read DuPont

  • Rising ROE from margin = pricing power, operational improvement (good)
  • Rising ROE from turnover = better asset utilization (good)
  • Rising ROE from leverage = more debt, amplified risk (caution)
  • Falling ROE across all three = structural deterioration (red flag)

See DCF fair value for THYROCARE

Combine financial quality with intrinsic value.

See Fair Value →

DuPont decomposition from audited annual financials. Factual analysis, not investment advice.

THYROCARE DuPont Analysis — ROE 16.7% | YieldIQ